These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Micro-RNA in disease and gene therapy. Lundstrom K Curr Drug Discov Technol; 2011 Jun; 8(2):76-86. PubMed ID: 21513487 [TBL] [Abstract][Full Text] [Related]
3. Regulation of the MIR155 host gene in physiological and pathological processes. Elton TS; Selemon H; Elton SM; Parinandi NL Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696 [TBL] [Abstract][Full Text] [Related]
4. Micromanaging vascular biology: tiny microRNAs play big band. Sen CK; Gordillo GM; Khanna S; Roy S J Vasc Res; 2009; 46(6):527-40. PubMed ID: 19571573 [TBL] [Abstract][Full Text] [Related]
5. microRNAs in Cardiovascular Disease: Small Molecules but Big Roles. Yan B; Wang H; Tan Y; Fu W Curr Top Med Chem; 2019; 19(21):1918-1947. PubMed ID: 31393249 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-based therapeutics for cancer. Wang V; Wu W BioDrugs; 2009; 23(1):15-23. PubMed ID: 19344188 [TBL] [Abstract][Full Text] [Related]
7. MicroRNAs and ultraconserved genes as diagnostic markers and therapeutic targets in cancer and cardiovascular diseases. Edwards JK; Pasqualini R; Arap W; Calin GA J Cardiovasc Transl Res; 2010 Jun; 3(3):271-9. PubMed ID: 20560048 [TBL] [Abstract][Full Text] [Related]
8. Implication of microRNAs in the cardiovascular system. Scalbert E; Bril A Curr Opin Pharmacol; 2008 Apr; 8(2):181-8. PubMed ID: 18243792 [TBL] [Abstract][Full Text] [Related]
9. MicroRNAs: role in cardiovascular biology and disease. Zhang C Clin Sci (Lond); 2008 Jun; 114(12):699-706. PubMed ID: 18474027 [TBL] [Abstract][Full Text] [Related]
10. Decoy activity through microRNAs: the therapeutic implications. Almeida MI; Reis RM; Calin GA Expert Opin Biol Ther; 2012 Sep; 12(9):1153-9. PubMed ID: 22650365 [TBL] [Abstract][Full Text] [Related]
11. Synergy of microRNA and stem cell: a novel therapeutic approach for diabetes mellitus and cardiovascular diseases. Tyagi AC; Sen U; Mishra PK Curr Diabetes Rev; 2011 Nov; 7(6):367-76. PubMed ID: 21864292 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-21: from cancer to cardiovascular disease. Jazbutyte V; Thum T Curr Drug Targets; 2010 Aug; 11(8):926-35. PubMed ID: 20415649 [TBL] [Abstract][Full Text] [Related]
13. miRNA and cancer; computational and experimental approaches. Tutar Y Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575 [TBL] [Abstract][Full Text] [Related]
14. MicroRNAs as a therapeutic target for cardiovascular diseases. Mishra PK; Tyagi N; Kumar M; Tyagi SC J Cell Mol Med; 2009 Apr; 13(4):778-89. PubMed ID: 19320780 [TBL] [Abstract][Full Text] [Related]
15. Role of specific microRNAs in regulation of vascular smooth muscle cell differentiation and the response to injury. Song Z; Li G J Cardiovasc Transl Res; 2010 Jun; 3(3):246-50. PubMed ID: 20543900 [TBL] [Abstract][Full Text] [Related]
16. MicroRNAs in cardiovascular diseases: biology and potential clinical applications. Kartha RV; Subramanian S J Cardiovasc Transl Res; 2010 Jun; 3(3):256-70. PubMed ID: 20560047 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic microRNA strategies in human cancer. Li C; Feng Y; Coukos G; Zhang L AAPS J; 2009 Dec; 11(4):747-57. PubMed ID: 19876744 [TBL] [Abstract][Full Text] [Related]
18. Development of microRNA therapeutics is coming of age. van Rooij E; Kauppinen S EMBO Mol Med; 2014 Jul; 6(7):851-64. PubMed ID: 24935956 [TBL] [Abstract][Full Text] [Related]
19. MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases. Pan ZW; Lu YJ; Yang BF Acta Pharmacol Sin; 2010 Jan; 31(1):1-9. PubMed ID: 19966833 [TBL] [Abstract][Full Text] [Related]
20. Using artificial microRNA sponges to achieve microRNA loss-of-function in cancer cells. Tay FC; Lim JK; Zhu H; Hin LC; Wang S Adv Drug Deliv Rev; 2015 Jan; 81():117-27. PubMed ID: 24859534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]